FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095296839> ?p ?o ?g. }

• W2095296839 abstract "Chemokine receptor CCR5, a G protein-coupled receptor (GPCR), has been shown as a viable target in drug discovery due to its involvement in HIV entry and cancer. In HIV pathogenesis, CCR5 acts as an essential co-receptor for HIV invasion into host cells; whereas in cancer, it provides a pro-inflammatory environment promoting cell invasion and proliferation in several cancers. Within those cancers, prostate cancer specimens have also been shown to over express CCR5. Thus, development of CCR5 antagonists may provide novel prostate cancer therapy. Several small molecule CCR5 antagonists have been developed as anti-prostate cancer such as anibamine and carboxymethyl-glucan (CMG). In this paper, we designed a series of N(5(1benzylpiperidin4yl)2hydroxyphenyl)formamide derivatives as anti-prostate cancer. The developed model was conducted based on molecular docking studies and validated by standard QSAR parameters. The QSAR analysis using a series of N(5(1benzylpiperidin4yl)2hydroxyphenyl)formamide derivatives was successfully carried out to build a statistically significant model possessing a good correlative and predictive capability for the inhibition CCR5 antagonists. This analysis could be help in developing potential inhibition candidates for an anti-prostate cancer. Docking simulation was performed by AutoDock 4.1.5.6. The results showed that the main parameters of QSAR equation for inhibition CCR5 activity were AM1_dipole, AM1_HOMO, ASA_H, AM1_E and mr with r 2 , q 2 and F of 0.865; 0.997216 and 4.233015, respectively. The docking results revealed that N-(5-(1-benzylpiperidin-4-yl)-2-hydroxyphenyl) formamide and its derivative can interact to binding sites of the studied CCR5 receptor formed hydrogen bond with Tyr37, Trp86, Tyr108, Phr182, Gln194, Ile198, Tyr251, Glu283, and Met287. They have the same pattern of hydrogen bonds with the known binding ligands maraviroc (PDB ID 4MBS) for CCR5." @default.
• W2095296839 created "2016-06-24" @default.
• W2095296839 creator A5014046281 @default.
• W2095296839 creator A5023016606 @default.
• W2095296839 creator A5036967543 @default.
• W2095296839 creator A5038009995 @default.
• W2095296839 creator A5069887124 @default.
• W2095296839 date "2015-01-01" @default.
• W2095296839 modified "2023-10-15" @default.
• W2095296839 title "Study on CCR5 Receptor Antagonists as an Anti-Prostate Cancer: Inhibition Activity, QSAR and Molecular Docking" @default.
• W2095296839 cites W1487542821 @default.
• W2095296839 cites W1992395686 @default.
• W2095296839 cites W2030060971 @default.
• W2095296839 cites W2055208054 @default.
• W2095296839 cites W2854832802 @default.
• W2095296839 cites W595606452 @default.
• W2095296839 doi "https://doi.org/10.2991/iccst-15.2015.9" @default.
• W2095296839 hasPublicationYear "2015" @default.
• W2095296839 type Work @default.
• W2095296839 sameAs 2095296839 @default.
• W2095296839 citedByCount "0" @default.
• W2095296839 crossrefType "proceedings-article" @default.
• W2095296839 hasAuthorship W2095296839A5014046281 @default.
• W2095296839 hasAuthorship W2095296839A5023016606 @default.
• W2095296839 hasAuthorship W2095296839A5036967543 @default.
• W2095296839 hasAuthorship W2095296839A5038009995 @default.
• W2095296839 hasAuthorship W2095296839A5069887124 @default.
• W2095296839 hasBestOaLocation W20952968391 @default.
• W2095296839 hasConcept C104317684 @default.
• W2095296839 hasConcept C121608353 @default.
• W2095296839 hasConcept C126322002 @default.
• W2095296839 hasConcept C159110408 @default.
• W2095296839 hasConcept C164126121 @default.
• W2095296839 hasConcept C185592680 @default.
• W2095296839 hasConcept C2775905019 @default.
• W2095296839 hasConcept C2780152424 @default.
• W2095296839 hasConcept C2780192828 @default.
• W2095296839 hasConcept C41685203 @default.
• W2095296839 hasConcept C502942594 @default.
• W2095296839 hasConcept C55493867 @default.
• W2095296839 hasConcept C71240020 @default.
• W2095296839 hasConcept C71924100 @default.
• W2095296839 hasConcept C86803240 @default.
• W2095296839 hasConcept C98274493 @default.
• W2095296839 hasConceptScore W2095296839C104317684 @default.
• W2095296839 hasConceptScore W2095296839C121608353 @default.
• W2095296839 hasConceptScore W2095296839C126322002 @default.
• W2095296839 hasConceptScore W2095296839C159110408 @default.
• W2095296839 hasConceptScore W2095296839C164126121 @default.
• W2095296839 hasConceptScore W2095296839C185592680 @default.
• W2095296839 hasConceptScore W2095296839C2775905019 @default.
• W2095296839 hasConceptScore W2095296839C2780152424 @default.
• W2095296839 hasConceptScore W2095296839C2780192828 @default.
• W2095296839 hasConceptScore W2095296839C41685203 @default.
• W2095296839 hasConceptScore W2095296839C502942594 @default.
• W2095296839 hasConceptScore W2095296839C55493867 @default.
• W2095296839 hasConceptScore W2095296839C71240020 @default.
• W2095296839 hasConceptScore W2095296839C71924100 @default.
• W2095296839 hasConceptScore W2095296839C86803240 @default.
• W2095296839 hasConceptScore W2095296839C98274493 @default.
• W2095296839 hasLocation W20952968391 @default.
• W2095296839 hasLocation W20952968392 @default.
• W2095296839 hasOpenAccess W2095296839 @default.
• W2095296839 hasPrimaryLocation W20952968391 @default.
• W2095296839 hasRelatedWork W1196898455 @default.
• W2095296839 hasRelatedWork W1568730085 @default.
• W2095296839 hasRelatedWork W1914679000 @default.
• W2095296839 hasRelatedWork W1976662380 @default.
• W2095296839 hasRelatedWork W1979281193 @default.
• W2095296839 hasRelatedWork W1979975281 @default.
• W2095296839 hasRelatedWork W2064818963 @default.
• W2095296839 hasRelatedWork W2146264548 @default.
• W2095296839 hasRelatedWork W2152006268 @default.
• W2095296839 hasRelatedWork W2186608105 @default.
• W2095296839 hasRelatedWork W2212028773 @default.
• W2095296839 hasRelatedWork W2342984936 @default.
• W2095296839 hasRelatedWork W2507480580 @default.
• W2095296839 hasRelatedWork W2577527614 @default.
• W2095296839 hasRelatedWork W2589057158 @default.
• W2095296839 hasRelatedWork W2955663742 @default.
• W2095296839 hasRelatedWork W3044130800 @default.
• W2095296839 hasRelatedWork W3087444140 @default.
• W2095296839 hasRelatedWork W3107670508 @default.
• W2095296839 hasRelatedWork W3205984892 @default.
• W2095296839 isParatext "false" @default.
• W2095296839 isRetracted "false" @default.
• W2095296839 magId "2095296839" @default.
• W2095296839 workType "article" @default.